Some of this has been mentioned but it is good to hear it from the CEO. In recent communication with Joel he confirmed the following:
- All 6 programs qualify for FDA fast track
- no new molecules are used in any of the 6 programs which accelerate FDA approval
- there is a news flow expected from now until the end of the year( my personal guess is that the news flow will star from July or after US listing)
- they are now working on the SEC filing, an announcement on dual listing will follow once done
- IHL received great interest from US investors through EAS and other channels as well
- all board members own shares paid for by their money, big part of the medical stuff as well ( they are all believers and work as hard and quick as they can to get things done)
I have bought more after this communication with him.
good luck to all.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-6193
-
-
- There are more pages in this discussion • 14,221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)